Array Biopharma Inc (NASDAQ:ARRY) shares are dipping almost 8% after the discouraging news broke that the biotech firm has decided to withdraw its …
Array Biopharma Inc (NASDAQ:ARRY) shares were soaring 17% yesterday on back of a second fiscal quarter update that has given investors signs of …
Cowen analyst Chris Shibutani remains sidelined, but optimistic on Lexicon Pharmaceuticals (NASDAQ:LXRX) after the firm released a positive top-line readout from InTandem2, the second of its three pivotal Phase III trials …
Shares of Juno Therapeutics Inc (NASDAQ:JUNO) fall as Wall Street continues to debate the unexpected patient deaths and clinical hold for the company’s Phase …
Cowen analyst Chris Shibutani weighed in on Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), after the drug maker announced that clinical data on brigatinib, its investigational anaplastic lymphoma …
On Monday, Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) presented updated clinical data from its ongoing Phase 1/2 trial on its investigational tyrosine kinase inhibitor, pipeline …
In a research report released Friday, Cowen analyst Chris Shibutani reiterated an Outperform rating on shares of Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) with a price …
In a research report issued Monday, Cowen analyst Chris Shibutani reiterated an Outperform rating on shares of Juno Therapeutics Inc (NASDAQ:JUNO), while reducing the …
